{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in Section 6.2.", "size": 136, "snippet_links": [{"key": "section-62", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "jb1en3K4Evu", "uri": "/contracts/jb1en3K4Evu#commercialization-plan", "label": "License Agreement (Astria Therapeutics, Inc.)", "score": 36.8631057739, "published": true}, {"hash": "cxBdFpYgubp", "uri": "/contracts/cxBdFpYgubp#commercialization-plan", "label": "Licensing Agreement", "score": 35.1718978882, "published": true}, {"hash": "cC8KnJw0tii", "uri": "/contracts/cC8KnJw0tii#commercialization-plan", "label": "Collaboration and License Agreement (Silverback Therapeutics, Inc.)", "score": 33.8514709473, "published": true}], "hash": "90b134ac043b2f73fb71cb97238d31df", "id": 1}, {"snippet": "has the meaning set forth in Section 4.3.", "size": 73, "snippet_links": [{"key": "section-43", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "3pcnvNTHA1O", "uri": "/contracts/3pcnvNTHA1O#commercialization-plan", "label": "Collaboration and License Agreement (REGENXBIO Inc.)", "score": 36.3593444824, "published": true}, {"hash": "7lrurpPU8Ur", "uri": "/contracts/7lrurpPU8Ur#commercialization-plan", "label": "License Agreement (UroGen Pharma Ltd.)", "score": 28.2635173798, "published": true}, {"hash": "9jnFebRyMe", "uri": "/contracts/9jnFebRyMe#commercialization-plan", "label": "License Agreement (Argos Therapeutics Inc)", "score": 26.3661880493, "published": true}], "hash": "551cc81da46b9affe35f96da2466b855", "id": 2}, {"snippet": "shall have the meaning set forth in Section 5.1(b).", "size": 33, "snippet_links": [], "samples": [{"hash": "huXnGMLo1xQ", "uri": "/contracts/huXnGMLo1xQ#commercialization-plan", "label": "License and Collaboration Agreement (Mannkind Corp)", "score": 37.1533203125, "published": true}, {"hash": "8A2hQcYNZUX", "uri": "/contracts/8A2hQcYNZUX#commercialization-plan", "label": "License and Collaboration Agreement (Mannkind Corp)", "score": 35.1546897888, "published": true}, {"hash": "1zEHNYrqenX", "uri": "/contracts/1zEHNYrqenX#commercialization-plan", "label": "License and Collaboration Agreement (UNITED THERAPEUTICS Corp)", "score": 33.585899353, "published": true}], "hash": "4cd3c4777e5de3141182432eae2ba1a0", "id": 3}, {"snippet": "means, with respect to Product, any and all plans and activities directed to the development, marketing, promotion, distribution, offering for sale, and selling of Product and importing Product for sale in the Territory in accordance with this Agreement any plan for Regulatory Approval and any Marketing Plan, as set forth in Annex B hereto.", "size": 31, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "plans-and", "type": "definition", "offset": [44, 53]}, {"key": "directed-to", "type": "definition", "offset": [65, 76]}, {"key": "the-development", "type": "clause", "offset": [77, 92]}, {"key": "offering-for-sale", "type": "definition", "offset": [130, 147]}, {"key": "in-the-territory", "type": "clause", "offset": [203, 219]}, {"key": "in-accordance-with", "type": "clause", "offset": [220, 238]}, {"key": "this-agreement", "type": "clause", "offset": [239, 253]}, {"key": "regulatory-approval", "type": "clause", "offset": [267, 286]}, {"key": "marketing-plan", "type": "definition", "offset": [295, 309]}, {"key": "annex-b", "type": "definition", "offset": [327, 334]}], "samples": [{"hash": "eqsLwYws6hd", "uri": "/contracts/eqsLwYws6hd#commercialization-plan", "label": "License & Supply Agreement (AEON Biopharma, Inc.)", "score": 32.7563323975, "published": true}, {"hash": "4FLZQtgeElT", "uri": "/contracts/4FLZQtgeElT#commercialization-plan", "label": "License & Supply Agreement (AEON Biopharma, Inc.)", "score": 32.7097892761, "published": true}, {"hash": "yDceHVzIaP", "uri": "/contracts/yDceHVzIaP#commercialization-plan", "label": "License & Supply Agreement (AEON Biopharma, Inc.)", "score": 32.7015724182, "published": true}], "hash": "d2ae6c68dc9f282732d23b84e77a2b2d", "id": 4}, {"snippet": "has the meaning set forth in Section 7.2 (Commercialization Plan).", "size": 23, "snippet_links": [{"key": "section-72", "type": "clause", "offset": [29, 40]}], "samples": [{"hash": "6ZpRVQVUQsD", "uri": "/contracts/6ZpRVQVUQsD#commercialization-plan", "label": "Exclusive License Agreement (CM Life Sciences III Inc.)", "score": 32.7563323975, "published": true}, {"hash": "QyVrboTOo", "uri": "/contracts/QyVrboTOo#commercialization-plan", "label": "License Agreement (Angion Biomedica Corp.)", "score": 32.0390129089, "published": true}, {"hash": "59l6alTBt2z", "uri": "/contracts/59l6alTBt2z#commercialization-plan", "label": "License and Collaboration Agreement (VistaGen Therapeutics, Inc.)", "score": 31.6146469116, "published": true}], "hash": "e77d5d9974497aa0e4e72cb100516c69", "id": 5}, {"snippet": "means the written plan for the Commercialization of the Product in the Territory, as updated in accordance with this Agreement.", "size": 22, "snippet_links": [{"key": "written-plan", "type": "clause", "offset": [10, 22]}, {"key": "commercialization-of-the-product", "type": "clause", "offset": [31, 63]}, {"key": "in-the-territory", "type": "clause", "offset": [64, 80]}, {"key": "in-accordance-with", "type": "clause", "offset": [93, 111]}, {"key": "this-agreement", "type": "clause", "offset": [112, 126]}], "samples": [{"hash": "ea5MYOCTSDq", "uri": "/contracts/ea5MYOCTSDq#commercialization-plan", "label": "License Agreement (Zai Lab LTD)", "score": 32.3538665771, "published": true}, {"hash": "gGAVsbBhtLp", "uri": "/contracts/gGAVsbBhtLp#commercialization-plan", "label": "License Agreement (Zai Lab LTD)", "score": 32.1622161865, "published": true}, {"hash": "dWfJQj0ksEe", "uri": "/contracts/dWfJQj0ksEe#commercialization-plan", "label": "License Agreement (Zai Lab LTD)", "score": 32.1622161865, "published": true}], "hash": "11536a3230cc3e45ab3cc2e04a0ee30a", "id": 6}, {"snippet": "shall have the meaning provided in Section 3.1.", "size": 17, "snippet_links": [{"key": "section-31", "type": "definition", "offset": [35, 46]}], "samples": [{"hash": "jYNpbLjCNEj", "uri": "/contracts/jYNpbLjCNEj#commercialization-plan", "label": "Development and License Agreement (Gw Pharmaceuticals PLC)", "score": 24.2936344147, "published": true}, {"hash": "5iddN2qCKB7", "uri": "/contracts/5iddN2qCKB7#commercialization-plan", "label": "Development and License Agreement (Gw Pharmaceuticals PLC)", "score": 24.2306632996, "published": true}, {"hash": "ZCxieljj8r", "uri": "/contracts/ZCxieljj8r#commercialization-plan", "label": "Development and License Agreement (Gw Pharmaceuticals PLC)", "score": 24.0444908142, "published": true}], "hash": "64d48497d8b3ff4db9416274141244f7", "id": 7}, {"snippet": "means the written commercialization plan attached as Appendix B of the Patent & Technology License Agreement.", "size": 16, "snippet_links": [{"key": "b-of", "type": "definition", "offset": [62, 66]}, {"key": "patent-technology-license-agreement", "type": "definition", "offset": [71, 108]}], "samples": [{"hash": "235x5LtFJ3m", "uri": "/contracts/235x5LtFJ3m#commercialization-plan", "label": "Patent & Technology License Agreement", "score": 31.3408622742, "published": true}, {"hash": "fyylFYfZBYS", "uri": "/contracts/fyylFYfZBYS#commercialization-plan", "label": "Patent & Technology License Agreement (American Boarding Co)", "score": 26.9712524414, "published": true}, {"hash": "cvoLlzSu5V8", "uri": "/contracts/cvoLlzSu5V8#commercialization-plan", "label": "Patent & Technology License Agreement (American Boarding Co)", "score": 26.9712524414, "published": true}], "hash": "535ecb96350b632df9c2552e61b03b1c", "id": 8}, {"snippet": "has the meaning set forth in Section 7.1(c).", "size": 16, "snippet_links": [], "samples": [{"hash": "5d7YyPKNNUt", "uri": "/contracts/5d7YyPKNNUt#commercialization-plan", "label": "License and Collaboration Agreement (Portola Pharmaceuticals Inc)", "score": 24.3456535339, "published": true}, {"hash": "hh56RRcZwNi", "uri": "/contracts/hh56RRcZwNi#commercialization-plan", "label": "License and Collaboration Agreement (Portola Pharmaceuticals Inc)", "score": 24.1950721741, "published": true}, {"hash": "f8ClBWXsfpb", "uri": "/contracts/f8ClBWXsfpb#commercialization-plan", "label": "License and Collaboration Agreement (Portola Pharmaceuticals Inc)", "score": 23.9705677032, "published": true}], "hash": "d26beb7bd29844dcb917cb0289034998", "id": 9}, {"snippet": "means the comprehensive plan for the commercialization of a Collaboration Product, as more specifically described in Section 6.1.1 hereof.", "size": 15, "snippet_links": [{"key": "comprehensive-plan", "type": "definition", "offset": [10, 28]}, {"key": "collaboration-product", "type": "definition", "offset": [60, 81]}, {"key": "more-specifically", "type": "clause", "offset": [86, 103]}], "samples": [{"hash": "gDhJHWmoka0", "uri": "/contracts/gDhJHWmoka0#commercialization-plan", "label": "Collaboration Agreement (Geltex Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "fBZucbrOq8e", "uri": "/contracts/fBZucbrOq8e#commercialization-plan", "label": "Collaboration Agreement (Genzyme Transgenics Corp)", "score": 18.0, "published": true}, {"hash": "ecPLVWG4w9A", "uri": "/contracts/ecPLVWG4w9A#commercialization-plan", "label": "Collaboration Agreement (GTC Biotherapeutics Inc)", "score": 18.0, "published": true}], "hash": "f5c7d0a9099c585f5e4f1c645767b8d1", "id": 10}], "next_curs": "CmMSXWoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIfY29tbWVyY2lhbGl6YXRpb24tcGxhbiMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "has the meaning set forth in Section 6.2.", "size": 822, "title": "Commercialization Plan", "id": "commercialization-plan", "examples": ["For clarity, on a country-by-country basis, upon entering into an Out-Licensing Transaction in accordance with the terms of this Article 10 (Out-Licensing Transaction) with respect to such country, neither Party will be required to continue any further research, Development and Commercialization activities pursuant to any Research Plan, Development Plan or <strong>Commercialization Plan</strong>, as applicable, for such country under this Agreement, unless otherwise contemplated in such Out-Licensing Transaction.", "For clarity, and without limiting the Parties\u2019 ability to amend the Research Plan pursuant to Section 3.2.2 (Initial Research Plan; Amendments to the Research Plan), the Development Plan pursuant to Section 6.3.2 (Initial Development Plan; Amendments to the Development Plan) or the <strong>Commercialization Plan</strong> pursuant to Section 8.3.2 (Initial <strong>Commercialization Plan</strong>; Amendments to the <strong>Commercialization Plan</strong>), [***], as applicable, may not [***].", "The JSC will hold meetings at such times as it elects to do so, but in no event will such meetings be held less frequently than [***] during the performance of the Research Plan, Development Plan or <strong>Commercialization Plan</strong>, as applicable, unless otherwise agreed by the Parties.", "On or before each anniversary of the Effective Date, the Parties will prepare an update to the <strong>Commercialization Plan</strong> and corresponding Commercialization Budget and will submit each update to the JSC to review, discuss, and determine whether to approve.", "The <strong>Commercialization Plan</strong> will include (a) all Commercialization and Manufacturing activities to be performed (b) timelines for the performance of all activities set forth therein, and (c) a Commercialization Budget for the conduct of activities set forth in such <strong>Commercialization Plan</strong>.", "Without limiting Section 10.1 (Out-Licensing Transactions), each Party will use Commercially Reasonable Efforts to perform the activities assigned to it in the <strong>Commercialization Plan</strong> in accordance with the timelines set forth therein and in accordance with this Article 8 (Commercialization); provided that, if the Parties have not yet entered into an Out-Licensing Transaction, then [***].", "Once reviewed, discussed, and approved by the JSC, each update to such <strong>Commercialization Plan</strong> (including any update to the Commercialization Budget) will become effective and supersede the previous <strong>Commercialization Plan</strong> and Commercialization Budget as of the date of such approval or at such other time as decided by the JSC.", "Each Party\u2019s responsibilities and obligations with respect to Manufacturing activities under this Agreement will be set forth in the Research Plan, Development Plan or <strong>Commercialization Plan</strong>, as applicable.", "In addition, from time to time, either Party may submit to the JSC any proposed update to the <strong>Commercialization Plan</strong> (e.g. to include additional Commercialization activities or revise the Commercialization Budget), and the JSC will review, discuss, and determine whether to approve any such update.", "Within [***] (which period may be extended by mutual agreement of the Parties) following the Commercialization Approval, the JSC will discuss in good faith and approve an initial <strong>Commercialization Plan</strong>."], "related": [["development-plan", "Development Plan", "Development Plan"], ["development-plans", "Development Plans", "Development Plans"], ["commercialization", "Commercialization", "Commercialization"], ["marketing-plan", "Marketing Plan", "Marketing Plan"], ["development-program", "Development Program", "Development Program"]], "related_snippets": [], "updated": "2026-04-19T04:24:51+00:00"}, "json": true, "cursor": ""}}